Metraipolis › archive › dc_0e596d1ff373

Unveiling biomarkers of telitacicept's efficacy in SLE treatment through proteomics and metabolomics — Europe PMC PMID:41859090

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41859090
DOI: 10.3389/fimmu.2026.1779880
License (as archived): solo-consultazione
Archived: 2026-11-05T04:05:45.283Z
SHA-256 of the archived text: c0c9d533ce213de6d844b8869cb0c2ca17fc9e81ff9241bf2628ec19f45c66a8
Stable URL of this page: https://metraipolis.com/documento/dc_0e596d1ff373

How to cite

Unveiling biomarkers of telitacicept's efficacy in SLE treatment through proteomics and metabolomics — Europe PMC PMID:41859090 — Europe PMC (en), https://europepmc.org/article/MED/41859090 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e596d1ff373 (Metraipolis archive dc_0e596d1ff373, sha256 c0c9d533ce213de6d844b8869cb0c2ca17fc9e81ff9241bf2628ec19f45c66a8)

BibTeX

@misc{dc0e596d1ff373,
  title = {Unveiling biomarkers of telitacicept's efficacy in SLE treatment through proteomics and metabolomics — Europe PMC PMID:41859090},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41859090},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e596d1ff373; sha256 c0c9d533ce213de6d844b8869cb0c2ca17fc9e81ff9241bf2628ec19f45c66a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41859090. Agents can read the archived copy with the MCP tool read_document.